Target Gene/Pathway
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z other
No. | KEGG PATHWAY * On map, Yellow: Drug target, Red: Disease-related |
KEGG GENES * [Number of genes] |
KEGG DRUG * | DrugBank | Disease ID * [Number of diseases] |
1 | cAMP signaling pathway |
[2] GABBR1, GABBR2 | D00241 | Baclofen | [5] 2, 10, 13, 18, 149 |
2 | ECM-receptor interaction |
[1] SV2A | D08879 | Brivaracetam | [2] 149, 309 |
3 | Estrogen signaling pathway |
[2] GABBR1, GABBR2 | D00241 | Baclofen | [5] 2, 10, 13, 18, 149 |
4 | GABAergic synapse |
[2] GABBR1, GABBR2 | D00241 | Baclofen | [5] 2, 10, 13, 18, 149 |
5 | GnRH secretion |
[2] GABBR1, GABBR2 | D00241 | Baclofen | [5] 2, 10, 13, 18, 149 |
6 | Insulin secretion |
[1] SNAP25 | D00783 | Botulinum toxin type A | [13] 2, 5, 6, 7, 13, 15, 17, 36, 51, 70, 113, 149, 226 |
7 | Morphine addiction |
[2] GABBR1, GABBR2 | D00241 | Baclofen | [5] 2, 10, 13, 18, 149 |
8 | Neuroactive ligand-receptor interaction |
[2] GABBR1, GABBR2 | D00241 | Baclofen | [5] 2, 10, 13, 18, 149 |
9 | Synaptic vesicle cycle |
[1] SNAP25 | D00783 | Botulinum toxin type A | [13] 2, 5, 6, 7, 13, 15, 17, 36, 51, 70, 113, 149, 226 |
10 | Taste transduction |
[2] GABBR1, GABBR2 | D00241 | Baclofen | [5] 2, 10, 13, 18, 149 |
[2] SCN3A, SCN9A | D07299 | Lacosamide | [3] 2, 46, 149 |